Angelini Labopharm Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
1,001
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Angelini Labopharm General Information
Description
Distributor of pharmaceutical products. The company is engaged the commercialization and distribution of OLEPTRO™ drug to treat depression among adults.
Contact Information
Website
www.angelabo.us.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Angelini
Primary Office
- 202 Carnegie Center
- Suite 107
- Princeton, NJ 08540
- United States
Angelini Labopharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Angelini Labopharm Patents
Angelini Labopharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2013116917-A | Trazodone composition for once-daily dosing | Pending | 09-Sep-2005 | 0000000000 | 0 |
| AU-2006308449-A8 | Trazodone composition for once a day administration | Active | 09-Sep-2005 | 0000000000 | |
| AU-2006308449-B2 | Trazodone composition for once a day administration | Active | 09-Sep-2005 | 0000000000 | 0 |
| AU-2006308449-B8 | Trazodone composition for once a day administration | Active | 09-Sep-2005 | 0000000000 | 0 |
| ES-2389666-T3 | Trazodone composition for once-daily administration | Active | 09-Sep-2005 | A61K9/2072 |
Angelini Labopharm Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Angelini Labopharm Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|